scholarly journals PCN158 PATIENT BURDEN AND COSTS FOR THE TREATMENT OF MULTIPLE MYELOMA IN FINLAND IN 2009-2016, USING MULTIPLE DATA SOURCES: AN ELECTRONIC HOSPITAL DATABASE, MEDICAL CHART REVIEW, AND INTERVIEWS WITH HEALTHCARE PROFESSIONALS

2019 ◽  
Vol 22 ◽  
pp. S466
Author(s):  
S. Torvinen ◽  
V. Vihervaara ◽  
T. Miettinen ◽  
J. Jokelainen ◽  
M. Bauer ◽  
...  
Author(s):  
Nathalie Aubert ◽  
Isabelle Lyon-Pagès ◽  
Isabelle Carrard ◽  
Michel Suter ◽  
Friedrich Stiefel ◽  
...  

BMJ Open ◽  
2016 ◽  
Vol 6 (1) ◽  
pp. e009711 ◽  
Author(s):  
Takahisa Kawano ◽  
Kei Nishiyama ◽  
Hiroshi Morita ◽  
Osamu Yamamura ◽  
Atsuchi Hiraide ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
pp. 61 ◽  
Author(s):  
Wan Yen Lim ◽  
John Ong ◽  
Sharon Ong ◽  
Ying Hao ◽  
Hairil Rizal Abdullah ◽  
...  

The Maslach Burnout Inventory for healthcare professionals (MBI-HSS) and its abbreviated version (aMBI), are the most common tools to detect burnout in clinicians. A wide range in burnout prevalence is reported in anesthesiology, so this study aimed to ascertain which of these two tools most accurately detected burnout in our anesthesiology residents. The MBI-HSS and aMBI were distributed amongst 86 residents across three hospitals, with a total of 58 residents completing the survey (67.4% response rate; 17 male and 41 female). Maslach-recommended cut-offs for the MBI-HSS and the aMBI with standard cut-offs were used to estimate burnout prevalence, and actual prevalence was established clinically by a thorough review of multiple data sources. Burnout proportions reported by the MBI-HSS and aMBI were found to be significantly different; 22.4% vs. 62.1% respectively (p < 0.0001). Compared to the actual prevalence of burnout in our cohort, the MBI-HSS detected burnout most accurately; area under receiver operating characteristic of 0.99 (95% confidence interval (CI): 0.92–1.0). Although there was a good correlation between the MBI-HSS and aMBI subscale scores, the positive predictive value of the aMBI was poor; 33.3% (95% CI:27.5–39.8%), therefore caution and clinical correlation are advised when using the aMBI tool because of the high rates of false-positives.


Drug Safety ◽  
2019 ◽  
Vol 42 (9) ◽  
pp. 1071-1080 ◽  
Author(s):  
Loreen Straub ◽  
Joshua J. Gagne ◽  
Judith C. Maro ◽  
Michael D. Nguyen ◽  
Nicolas Beaulieu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document